Consider Nuances of Esketamine and Ketamine for Depression

June 2025

We’re getting questions about the role of Rx nasal esketamine (Spravato) or IV ketamine for treatment-resistant depression.

Esketamine nasal spray was first approved for use in COMBINATION with an oral antidepressant. Now, it can also be used as monotherapy.

Evidence suggests that esketamine nasal spray alone statistically improves depression symptom scores when compared to placebo after 4 weeks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote